Total number of projects: 4
As coordinator: 0
As participant: 2
Sole participant: 2
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 443.213 | 0 | 443.213 | 2 | ||
2011 | 0 | 779.997 | 12.527 | 1 | ||
2010 | 0 | 2.000.000 | 100.000 | 1 |
Total number of partners: 762
Partner loyalty:
Frequent Partner: (> 2 projects): 319
Rare Partner: 443
Frequent / Rare Partner Ratio: 0.72
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-07-01 | Identification of drug-resistance genes for the development of effective combined therapies for melanoma | MELANOMA DRUG RESIST | coordinator | 221.606 | 1 |
2014-05-01 | The Role of Protein N-Glycosylation in Bone and Energy Homeostasis | SUGARYBONE | coordinator | 221.606 | 1 |
2011-10-01 | Coordinating the cooperation of the ESFRI project Infrafrontier with the International Phenotyping Consortium (IMPC) | InfraCoMP | participant | 779.997 | 9 |
2010-10-01 | Sharing capacity across Europe in high-throughput sequencing technology to explore genetic variation in health and disease | GEUVADIS | participant | 2.000.000 | 17 |